Sulfalene
Appearance
Clinical data | |
---|---|
Trade names | Eadazine, Kelfizina, Kelfizine W, Longum |
Other names | Sulfametopyrazine |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral[1] |
ATC code | |
Pharmacokinetic data | |
Protein binding | 60 to 80%[1] |
Elimination half-life | 60 to 65 hours[1] |
Excretion | Urinary[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.278 |
Chemical and physical data | |
Formula | C11H12N4O3S |
Molar mass | 280.304 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Sulfalene (INN, USAN) or sulfametopyrazine (BAN) is a long-acting sulfonamide antibacterial used for the treatment of chronic bronchitis, urinary tract infections and malaria.[2][3] There are only two countries in which it is currently still marketed: Thailand and Ireland.[3]
Synthesis
See also
References
- ^ a b c d "Sulfalene". MIMS Drug Information System. Retrieved 26 August 2011.
- ^ DrugBank DB00664
- ^ a b Brayfield, A, ed. (9 May 2013). "Sulfametopyrazine". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 28 March 2014.
- ^ Camerino, B.; Palamidessi, G., Gazz. Chim. Ital., (1960) 90, 1815.